In vitro reactions of butadiene monoxide with single- and double-stranded DNA: Characterization and quantitation of several purine and pyrimidine adducts

Carcinogenesis

Volumn 20, Issue 2, 1999, Pages 285-292

  Selzer, Rebecca R ^a,b   Elfarra, Adrian A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 EPOXY 3 BUTENE; DOUBLE STRANDED DNA; PURINE; PYRIMIDINE; SINGLE STRANDED DNA;

ALKYLATION; ARTICLE; CARCINOGENESIS; CHEMICAL STRUCTURE; DNA ADDUCT; HYDROGEN BOND; HYDROLYSIS; METABOLITE; MUTAGENESIS; PRIORITY JOURNAL; THYMUS;

EID: 0032907873     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.2.285     Document Type: Article

References (50)

1. Divine, B.J., Wendt, J.K. and Hartman, C.M. (1993) Cancer mortality among workers at a butadiene production facility. In Sorsa, M., Peltonen, K., Vianio, H. and Hemminki, K. (eds) Butadiene and Styrene: Assessment of Health Hazards. IARC Scientific Publications no. 127, IARC, Lyon, pp. 345-362.
2. Santos-Burgoa, C. Matanoski, G.M., Zeger, S. and Schwartz, L. (1992) Lymphohematopoietic cancer in styrene-butadiene polymerization workers. Am. J. Epidemiol., 136, 843-854.
3. Melnick, R.L., Huff, J., Chou, B.J. and Miller, R.A. (1990) Carcinogenicity of 1,3-butadiene in C57BL/6×CH3 F1 mice at low exposure concentrations. Cancer Res., 50, 6592-6599.
4. Owen, P.E., Glaister, J.F., Gaunt, I.F. and Pullinger, D.H. (1987) Inhalation toxicity studies with 1,3-butadiene. 3. Two year toxicity/carcinogenicity study in rats. Am. Ind. Hyg. Assoc. J., 48, 407-413.
5. de Meester, C., Poncelet, F. Roberfroid, M. and Mercier, M. (1980) The mutagenicity of butadiene towards Salmonella typhimurium. Toxicol. Lett., 6, 125-130.
6. Bolt, H.M., Schmiedel, G., Gilser, J.G., Rolzhauser, H.P., Lieser, K., Wistuba, D. and Schurig, V. (1983) Biological activation of 1,3-butadiene to vinyl oxirane by rat liver microsomes and expiration of the reactive metabolite by exposed rats. J. Cancer Res. Clin. Oncol., 106, 112-116.
7. Elfarra, A.A., Duescher, R.J. and Pasch, C.M. (1991) Mechanisms of 1,3-butadiene oxidations to butadiene monoxide and crotonaldehyde by mouse liver microsomes and chloroperoxidase. Arch. Biochem. Biophys., 286, 244-251.
8. Sharer, J.E., Duescher, R.J. and Elfarra, A.A. (1992) Species and tissue differences in the microsomal oxidation of 1,3-butadiene and the glutathione conjugation of butadiene monoxide in mice and rats. Possible role in 1,3-butadiene-induced toxicity. Drug. Metab. Dispos., 20, 658-664.
9. Duescher, R.J. and Elfarra, A.A. (1992) 1,3-Butadiene oxidation by human myeloperoxidase. Role of chloride ion in catalysis of divergent pathways. J. Biol. Chem., 267, 19859-19865.
10. Duescher, R.J. and Elfarra, A.A. (1994) Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1. Arch. Biochem. Biophys., 311, 342-349.
11. de Meester, C., Poncelet, F., Roberfroid, M. and Mercier, M. (1978) Mutagenicity of butadiene and butadiene monoxide. Biochem. Biophys. Res. Commun., 80, 298-305.
12. Wade, M.J., Moyer, J.W. and Hine, C.H. (1979) Mutagenic action of a series of epoxides. Mutat. Res., 66, 367-371.
13. Van Duuren, P.L., Nelson, N., Orris, L., Palmes, E.D. and Schmitt, F.L. (1963) Carcinogenicity of epoxides, lactones and peroxy compounds. J. Natl Cancer Inst., 31, 41-55.
14. Van Duuren, B.L., Langseth, L., Orris, L., Teebor, G., Nelson, N. and Kuschner, M. (1966) Carcinogenicity of epoxides, lactones and peroxy compounds. IV. Tumor response in epithelial and connective tissue in mice and rats. J. Natl Cancer Inst., 37, 825-838.
15. Cochrane, J.E. and Skopek, T.R. (1994) Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis, 15, 713-717.
16. Cochrane, J.E. and Skopek, T.R. (1994) Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in T cells from exposed B6C3F1 mice and Sprague-Dawley rats. Carcinogenesis, 15, 719-723.
17. Ward, J.B., Ammenheuser, M.M., Bechtold, W.E., Whorton, E.B. and Legator, M.S. (1994) hprt mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant. Environ. Health Perspect., 102 (suppl. 9), 79-85.
18. Sasidek, M., Norppa, H. and Sorsa, M. (1991) 1,3-Butadiene and its epoxides induce sister-chromatid exchanges in human lymphocytes in vitro. Mutat. Res., 261, 117-121.
19. Tice, R.R., Boucher, R., Luke, C.A. and Shelby, M.D. (1987) Comparative cytogenetic analysis of bone marrow damage induced in male B6C3F1 mice by multiple exposures to gaseous 1,3-butadiene. Environ. Mutagen., 9, 235-250.
20. Cunningham, M.J., Choy, W.N., Arce, G.T. Rickard, L.B., Vlachos, D.A., Kinney, L.A. and Sarrif, A.M. (1986) In vivo sister chromatid exchange and micronucleus induction studies with 1,3-butadiene in B6C3F1 mice and Sprague-Dawley rats. Mutagenesis, 1, 449-452.
21. 14C]1,3-butadiene. Toxicol. Lett., 30, 131-136.
22. Recio, L. and Meyer, K.G. (1995) Increased frequency of mutations at A:T base pairs in the bone marrow of B6C3F1 lacI transgenic mice exposed to 1,3-butadiene. Environ. Mol. Mutagen., 26, 1-8.
23. Citti, L. Gervasi, P.G., Turchi, G., Bellucci, G. and Bianchini, R. (1984) The reaction of 3,4-epoxy-1-butene with deoxyguanosine and DNA in vitro: synthesis and characterization of the main adducts. Carcinogenesis, 5, 47-52.
24. th ASMS Conference on Mass Spectrometry and Allied Topics, Portland, OR, 12-16 May, p. 315.
25. 6-adenine adducts. Carcinogenesis, 16, 2999-3007.
26. 7-guanosine adducts of butadiene monoxide. Chem. Res. Toxicol., 9, 126-132.
27. 1 -adenosine adducts as major initial products. Chem. Res. Toxicol., 9, 875-881.
28. 3-deoxyuridine adducts of butadiene monoxide. Arch. Biochem. Biophys., 343, 63-72.
29. Selzer, R.R. and Elfarra, A.A. (1997) Characterization of four N-3-thymidine adducts formed in vitro by the reaction of thymidine and butadiene monoxide. Carcinogenesis, 18, 1993-1998.
30. Tretyakova, N., Lin, Y., Sangaiah, R., Upton, P.B. and Swenberg, J.A. (1997) Identification and quantitation of DNA adducts from calf thymus DNA exposed to 3,4-epoxy-1-butene. Carcinogenesis, 18, 137-147.
31. Plna, K., Segerbäck, D. and Schweda, E.K.H. (1996) DNA adduct formation by allyl glycidyl ether. Carcinogenesis, 17, 1465-1471.
32. Beranek, D.T., Weis, C. and Swenson, D.H. (1980) A comprehensive quantitative analysis of methylated and ethylated DNA using high pressure liquid chromatography. Carcinogenesis, 1, 595-606.
33. Singer, B. (1972) Reaction of guanosine with ethylating agents. Biochemistry, 11, 3939-3947.
34. Marmur, J. and Doty, P. (1962) Determination of the base composition of deoxyribonucleic acid from its thermal denaturation temperature. J. Mol. Biol., 5, 109-118.
35. Li, F., Segal, A. and Solomon, J.J. (1992) In vitro reaction of ethvlene oxide with DNA and characterization of DNA adducts. Chem. Biol. Interact., 83, 35-54.
36. Solomon, J.J., Mukai, F., Fedyk, J. and Segal, A. (1988) Reactions of propylene oxide with 2′-deoxynucleosides and in vitro with calf thymus DNA. Chem. Biol. Interact., 67, 275-294.
37. Carrell, H.L., Glusker, J.P., Moschel, R.C., Hudgins, W.R. and Dipple, A. (1981) Crystal structure of a carcinogen:nucleoside adduct. Cancer Res., 41, 2230-2234.
38. Lawley, P.D. and Brookes, P. (1963) Further studies on the alkylation of nucleic acids and their constituent nucleotides. Biochem. J., 89, 127-138.
39. Kunkel, T.A. (1984) Mutational specificity of depurination. Proc. Natl Acad. Sci. USA, 81, 1494-1498.
40. Drinkwater, N.R., Miller, E.C. and Miller, J.A. (1980) Estimation of apurinic/ apyrimidinic sites and phosphotriesters in deoxyribonucleic acid treated with electrophilic carcinogens and mutagens. Biochemistry, 19, 5087-5092.
41. Klinedinst, D.K. and Drinkwater, N.R. (1992) Mutagenesis by apurinic sites in normal and ataxia telangiectasia human lymphoblastoid cells. Mol. Carcinogen., 6, 32-12.
42. Solomon, J.J., Singh, U.S. and Segal, A. (1993) In vitro reactions of 2′-cyanoethylene oxide with calf thymus DNA. Chem. Biol. Interact., 88, 115-135.
43. Savela, K., Hesso, A. and Hemminki, K. (1986) Characterization of reaction products between styrene oxide and deoxynucleosides and DNA. Chem. Biol. Interact., 60, 25-246.
44. Fujii, R., Saito, B. and Terahara, N. (1986) Purines. XXVII. Hydrolytic deamination versus Dimroth rearrangement in the 9-substituted purine ring: effect of an omega-hydroxyalkyl group at the 1-position. Chem. Pharm. Bull., 34, 1094-1107.
45. 6-positions. Chem. Res. Toxicol., 8, 389-395.
46. 6-(2-carboxyethyl)adenine in single stranded DNA. Chem. Biol. Interact., 28, 333-344.
47. Bhanot, O.S., Singh, U.S. and Solomon, J.J. (1994) The role of 3-hydroxyethyldeoxyuridine in mutagenesis by ethvlene oxide. J. Biol. Chem., 269, 30056-30064.
48. Segal, A., Solomon, J.J. and Mukai, F. (1990) In vitro reactions of glycidol with pyrimidine bases in calf thymus DNA. Cancer Biochem. Biophys., 11, 59-67.
49. Dizdaroglu, M., Karadaya, A., Jaruga, P., Slupphaug, G. and Krokan, H.E. (1996) Novel activities of human uracil DNA N-glycosylase for cytosine-derived products of oxidative DNA damage. Nucleic Acids Res., 24, 418-422.
50. Hemminki, K. (1983) Nucleic acid adducts of chemical carcinogens and mutagens. Arch. Toxicol., 52, 249-285.